Chemomab Therapeutics Ltd. (CMMB)
NASDAQ·Healthcare·Biotechnology
$1.51
+5.59%
Mkt Cap $12.31M
No analyst coverage available
We don't have analyst ratings or price target data for Chemomab Therapeutics Ltd. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.